REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Apoteka Farmanea Beograd (Serbia)

Main Activities: Pharmacies and Drug Stores
Full name: Apoteka Farmanea Beograd Profile Updated: July 06, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Apoteka Farmanea Beograd is a company based in Serbia, with its head office in Belgrade. The company operates in the Pharmacies and Drug Stores sector. Apoteka Farmanea Beograd currently employs 235 (2019) people. The latest financial highlights indicate a net sales revenue increase of 108.04% in 2022. Its’ total assets recorded a growth of 31.52%. The net profit margin of Apoteka Farmanea Beograd decreased by 0.84% in 2022.

Headquarters
Milosa Pocerca 25
Belgrade; Belgrade;

Contact Details: Purchase the Apoteka Farmanea Beograd report to view the information.

Website: http://www.farmanea.co.rs

Basic Information
Total Employees:
Purchase the Apoteka Farmanea Beograd report to view the information.
Outstanding Shares:
Purchase the Apoteka Farmanea Beograd report to view the information.
Registered Capital:
Purchase the Apoteka Farmanea Beograd report to view the information.
Financial Auditors:
Purchase the Apoteka Farmanea Beograd report to view the information.
Incorporation Date:
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Representative
Purchase this report to view the information.
Representative
Company Performance
Financial values in the chart are available after Apoteka Farmanea Beograd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
108.04%▲
Total operating revenue
106.61%▲
Operating profit (EBIT)
-185.26%▼
EBITDA
-51.07%▼
Net Profit (Loss) for the Period
-161.02%▼
Total assets
31.52%▲
Total equity
-88.38%▼
Operating Profit Margin (ROS)
-0.76%▼
Net Profit Margin
-0.84%▼
Return on Equity (ROE)
-1196.23%▼
Debt to Equity Ratio
4863.45%▲
Quick Ratio
-0.05%▼
Cash Ratio
-0.06%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo